David W. Ollila - Concepedia

Author

David W. Ollila

University of North Carolina at Chapel Hill ORCID

Also Known As

Anton-Culver, Hoda, Ballman, Karla V., Begg, Colin B., Berry, Donald A., Blizard, Lillian Burdick, Carey, Lisa A., Chan, Keefe T., Cust, Anne E., D Ollila, D. Ollila

350

Publications

12.6K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill UNC Lineberger Comprehensive Cancer Center Memorial Sloan Kettering Cancer Center Moffitt Cancer Center The University of Sydney

About

David W. Ollila is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	51	2.3K
2	Health Sciences	11	11	469
3	Engineering	2	2	49
4	Nursing	1	1	34
5	Biostatistics	1	1	33

David W. Ollila

118

Publications

11.3K

Citations

H-Index

Page 1

	Year	Citations
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes Lisa A. Carey, Elizabeth Claire Dees, Lynda Sawyer, Clinical Cancer Research	2007	2.1K
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis Armando E. Giuliano, Karla V. Ballman, Linda McCall, JAMA	2017	1.8K
Histopathologic Validation of the Sentinel Lymph Node Hypothesis for Breast Carcinoma Roderick R. Turner, David W. Ollila, David L. Krasne, Annals of Surgery	1997	617
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib Lisa A. Carey, Donald A. Berry, Constance Cirrincione, Journal of Clinical Oncology	2015	429
Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma Study Nancy E. Thomas, Klaus J. Busam, Lynn From, Journal of Clinical Oncology	2013	270
Surgical Resection for Melanoma Metastatic to the Gastrointestinal Tract David W. Ollila Archives of Surgery	1996	266
Optimal Histopathologic Examination of the Sentinel Lymph Node for Breast Carcinoma Staging Roderick R. Turner, David W. Ollila, Stacey L. Stern, The American Journal of Surgical Pathology	1999	217
Prolonged Survival After Complete Resection of Disseminated Melanoma and Active Immunotherapy With a Therapeutic Cancer Vaccine Eddy C. Hsueh, Richard Essner, Leland J. Foshag, Journal of Clinical Oncology	2002	202
American Joint Committee on Cancer Tumor–Node–Metastasis Stage After Neoadjuvant Chemotherapy and Breast Cancer Outcome Lisa A. Carey, Richard Metzger, Elizabeth Claire Dees, JNCI Journal of the National Cancer Institute	2005	200
Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates Mehra Golshan, Constance Cirrincione, William M. Sikov, Annals of Surgery	2015	193

Page 1